Q3 Combined Ratio improves 317 bps to 98.9% driven by Loss Ratio moderationCHENNAI, India, Jan. 30, 2026 /PRNewswire/ -- Star Health…
SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced…
DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the…
SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
CHENNAI, India, Oct. 1, 2025 /PRNewswire/ -- Star Health and Allied Insurance Company Limited (Star Health), India's leading standalone health…